Data Code Sets
To receive email updates about this page, enter your email address:
For more information on background and concepts see Understanding the Rules for Creating CVX and MVX Codes [5 pages]
View archived 2015 Edition Versioned Codes
More ways to access CDC’s Vaccine Code Set information: Code Set Viewpoint search/browse website and REST Web Service
COVID-19 Vaccine Related Codes
Information regarding COVID-19 Emergency Use Authorization (EUA) vaccine codes and crosswalks can be found here.
Registered users can now access COVID-19 vaccine lot numbers and expiration dates provided to CDC by the vaccine manufacturer. COVID-19 Vaccine Lot Number and Expiration Date Tool
Seasonal Influenza Codes and Crosswalk
This new format includes all seasonal influenza vaccines for the 2022/2023 season in a single Excel crosswalk table that provides the CVX, MVX, NDC Unit of Sale, NDC Unit of Use, and CPT (*) codes for each vaccine.
(*) Please note that the CPT codes shown for each vaccine crosswalk are not mapped to the NDC codes, but are mapped to the CVX codes shown. These are reference CPT codes for vaccine categorization and are not intended to represent billable codes.
CVX Code | CVX Short Description | Sale Proprietary Name | Sale Labeler | MVX Code | Unit of Sale NDC11 | Unit of Use NDC11 | Presentation | CPT Code | CPT Description |
---|---|---|---|---|---|---|---|---|---|
149 | influenza, live, intranasal, quadrivalent | FluMist Quadrivalent | MedImmune, LLC | MED | 66019-309-10 | 66019-309-01 | APPLICATOR .2 mL | 90672 | Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use |
150 | influenza, injectable, quadrivalent, preservative free | Flulaval Quadrivalent | ID Biomedical Corporation of Quebec | IDB | 19515-0808-52 | 19515-0808-41 | SYRINGE, .5 mL | 90686 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
150 | influenza, injectable, quadrivalent, preservative free | FLUZONE QUADRIVALENT | Sanofi Pasteur Inc. | PMC | 49281-0422-10 | 49281-0422-58 | VIAL, .5 mL, SINGLE-DOSE | 90686 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
150 | influenza, injectable, quadrivalent, preservative free | FLUZONE QUADRIVALENT | Sanofi Pasteur Inc. | PMC | 49281-0422-50 | 49281-0422-88 | SYRINGE, .5 mL | 90686 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
150 | influenza, injectable, quadrivalent, preservative free | FLUARIX QUADRIVALENT | GlaxoSmithKline Biologicals SA | SKB | 58160-0890-52 | 58160-0890-41 | SYRINGE, .5 mL | 90686 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
150 | Influenza, injectable, quadrivalent, preservative free | Afluria Quadrivalent | Seqirus PTY LTD. | SEQ | 33332-0322-03 | 33332-0322-04 | SYRINGE, .5 mL | 90686 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
158 | influenza, injectable, quadrivalent | FLUZONE QUADRIVALENT | Sanofi Pasteur Inc. | PMC | 49281-0637-15 | 49281-0637-78 | VIAL, 5 mL, MULTI-DOSE | 90687 | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use |
90688 | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | ||||||||
158 | influenza, injectable, quadrivalent, contains preservative | Afluria Quadrivalent | Seqirus PTY LTD. | SEQ | 33332-0422-10 | 33332-0422-11 | VIAL, 5 mL, MULTI-DOSE | 90687 | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use |
90688 | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | ||||||||
171 | Influenza, injectable, MDCK, preservative free, quadrivalent | FLUCELVAX QUADRIVALENT | Seqirus Inc. | SEQ | 70461-0322-03 | 70461-0322-04 | SYRINGE, .5 mL | 90674 | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
185 | influenza, recombinant, quadrivalent,injectable, preservative free | Flublok Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | PMC | 49281-0722-10 | 49281-0722-88 | SYRINGE, .5 mL | 90682 | Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
186 | Influenza, injectable, MDCK, quadrivalent, preservative | FLUCELVAX QUADRIVALENT | Seqirus Inc. | SEQ | 70461-0422-10 | 70461-0422-11 | VIAL, 5 mL, MULTI-DOSE | 90756 | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use |
197 | influenza, high-dose, quadrivalent | FLUZONE High-Dose Quadrivalent Northern Hemisphere | Sanofi Pasteur Inc. | PMC | 49281-0122-65 | 49281-0122-88 | SYRINGE, .7 mL | 90662 | Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use |
205 | Influenza vaccine, quadrivalent, adjuvanted | FLUAD QUADRIVALENT | Seqirus, Inc. | SEQ | 70461-0122-03 | 70461-0122-04 | SYRINGE, .5 mL | 90694 | Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use |
CVX Code | CVX Short Description | Sale Proprietary Name | Sale Labeler | MVX Code | Unit of Sale NDC11 | Unit of Use NDC11 | Presentation | CPT Code | CPT Description |
---|---|---|---|---|---|---|---|---|---|
200 | influenza, Southern Hemisphere, pediatric, preservative free | FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | PMC | NA | NA | SYRINGE, 0.25 mL | NA | NA |
201 | influenza, Southern Hemisphere, preservative free | FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | PMC | 49281-0323-50 | 49281-0323-88 | SYRINGE, 0.5 mL | NA | NA |
202 | influenza, Southern Hemisphere, quadrivalent, with preservative | FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | PMC | 49281-0355-15 | 49281-0355-78 | VIAL, MULTI-DOSE, 5 mL | NA | NA |
231 | influenza, Southern Hemisphere, high-dose, quadrivalent | FLUZONE High-Dose Quadrivalent Southern Hemisphere | Sanofi Pasteur Inc. | PMC | 49281-0379-50 | 49281-0379-88 | SYRINGE, .7 mL | NA | NA |